Welcome to Janssen Pharmaceuticals Medical Affairs Booth 709
At Janssen, we are translating our understanding of the biology of underlying retinal diseases to develop needed therapies that preserve and enhance vision. Janssen’s clinical-stage retinal portfolio includes leading product candidates for inherited retinal diseases XLRP and achromatopsia. Janssen is also expanding into more common eye diseases, including age-related macular degeneration, diabetic retinopathy, and diabetic macular edema.
For more information, please visit www.retina.janssen.com
Follow @JanssenGlobal on Twitter, Instagram, and LinkedIn